PSMA PET/CT scans may predict prostate cancer recurrence, guide treatment
PSMA PET/CT scans may predict cancer-like-a-private-embarrassment-and-start-treating-it-a-public-health-crisis'>prostate cancer recurrence, guide treatment is drawing significant interest across the industry.
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to predict progression-free survival (PFS) and guide treatment planning in patients with rising prostate-specific antigen (PSA) levels following removal of the prostate.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Iberdrola completes acquisition of wind farm in state of Victoria, Australia
- Trump mixes diplomacy and flattery at peace board meeting
- Knicks snap Spurs' 11-game winning streak
- Netflix's version of Overcooked lets you play as Huntr/x
Source: Original →